Objective: Postoperative inflammation and pain remain key barriers to recovery after total knee arthroplasty (TKA). Metformin has anti-inflammatory properties, but its perioperative impact in TKA is unclear. This study evaluated whether regular metformin use reduces postoperative inflammation and pain in T2DM patients undergoing TKA.
Methods: In this single-center retrospective cohort study, patients with Type 2 diabetes mellitus (T2DM) who underwent primary TKA between December 2024 and May 2025 were included. Patients were grouped based on whether they had regularly taken metformin. 1:1 propensity score matching was performed to reduce baseline differences between groups, yielding 60 matched pairs. Inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), and D-dimer were measured preoperatively and on postoperative days 1 and 3. Pain was assessed using the Visual Analogue Scale (VAS) on postoperative days 1 and 3. Linear mixed-effects models were used to compare outcomes between groups after adjusting for residual confounders.
Results: In the matched cohort, the metformin group showed significantly lower CRP levels on postoperative day 3 (107.04 ± 49.19 vs. 130.91 ± 59.62 mg/L, p = 0.02), lower IL-6 levels on postoperative day 1 (62.22 ± 47.17 vs. 91.07 ± 41.55 pg/mL, p < 0.01), and postoperative day 3 (31.33 ± 20.84 vs. 57.74 ± 59.98 pg/mL, p < 0.01), and lower ESR levels on postoperative day 3 (45.40 ± 17.85 vs. 47.05 ± 20.19 mm/h, p = 0.03) than the non-metformin group. VAS pain scores on postoperative day 3 were also significantly lower in the metformin group (3.03 ± 1.03 vs. 4.15 ± 1.25, p < 0.01). These differences remained significant after adjusting for confounders.
Conclusion: Long-term regular use of metformin is associated with reduced acute inflammation and postoperative pain in T2DM patients undergoing TKA. As a widely used and well-tolerated medication, metformin holds promise as a low-cost, adjunctive therapeutic strategy to enhance early recovery and improve perioperative outcomes in diabetic patients undergoing TKA.
| [1] |
J. Gao, D. Xing, S. Dong, and J. Lin, “The Primary Total Knee Arthroplasty: A Global Analysis,” Journal of Orthopaedic Surgery and Research 15, no. 1 (2020): 190, https://doi.org/10.1186/s13018-020-01707-5.
|
| [2] |
C. H. Righolt, M. L. Armstrong, T. R. Turgeon, E. R. Bohm, and J. Sniderman, “Primary Total Knee Arthroplasty in Patients With BMI of ≥50 kg/m2: A Cohort Study With Long-Term Follow-Up,” Journal of Bone and Joint Surgery (American Volume) 107, no. 13 (2025): 1472–1479, https://doi.org/10.2106/jbjs.24.01060.
|
| [3] |
J. C. Wang, A. S. Piple, W. J. Hill, et al., “Computer-Navigated and Robotic-Assisted Total Knee Arthroplasty: Increasing in Popularity Without Increasing Complications,” Journal of Arthroplasty 37, no. 12 (2022): 2358–2364, https://doi.org/10.1016/j.arth.2022.06.014.
|
| [4] |
C. N. Carender, N. A. Glass, D. E. DeMik, J. M. Elkins, T. S. Brown, and N. A. Bedard, “Projected Prevalence of Obesity in Primary Total Knee Arthroplasty: How Big Will the Problem Get?,” Journal of Arthroplasty 37, no. 7 (2022): 1289–1295, https://doi.org/10.1016/j.arth.2022.03.003.
|
| [5] |
L. Boyce, A. Prasad, M. Barrett, et al., “The Outcomes of Total Knee Arthroplasty in Morbidly Obese Patients: A Systematic Review of the Literature,” Archives of Orthopaedic and Trauma Surgery 139, no. 4 (2019): 553–560, https://doi.org/10.1007/s00402-019-03127-5.
|
| [6] |
H. L. Paish, T. E. Baldock, C. S. Gillespie, et al., “Chronic, Active Inflammation in Patients With Failed Total Knee Replacements Undergoing Revision Surgery,” Journal of Orthopaedic Research 37, no. 11 (2019): 2316–2324, https://doi.org/10.1002/jor.24398.
|
| [7] |
M. S. Kim, J. J. Kim, K. H. Kang, M. J. Kim, and Y. In, “Diagnosis of Central Sensitization and Its Effects on Postoperative Outcomes Following Total Knee Arthroplasty: A Systematic Review and Meta-Analysis,” Diagnostics (Basel) 12, no. 5 (2022): 1248, https://doi.org/10.3390/diagnostics12051248.
|
| [8] |
T. Sonobe, T. Nikaido, M. Sekiguchi, Y. Kaneuchi, T. Kikuchi, and Y. Matsumoto, “The Impact of Central Sensitization on Perioperative Pain in TKA: A Retrospective Cohort Study,” Knee Surgery and Related Research 37, no. 1 (2025): 13, https://doi.org/10.1186/s43019-025-00263-8.
|
| [9] |
Y. Berkovich, E. C. Nissan, D. Maman, et al., “Diabetes and Total Knee Arthroplasty: A Nationwide Analysis of Complications, Hospitalization Outcomes and Revision Burden,” Knee Surgery, Sports Traumatology, Arthroscopy 33 (2025): 3250–3260, https://doi.org/10.1002/ksa.12696.
|
| [10] |
S. H. Hong, S. C. Kwon, J. H. Lee, S. Moon, and J. I. Kim, “Influence of Diabetes Mellitus on Postoperative Complications After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis,” Medicina (Kaunas, Lithuania) 60, no. 11 (2024): 1757, https://doi.org/10.3390/medicina60111757.
|
| [11] |
H. J. Park, M. J. Chang, T. J. Kim, et al., “Intravenous Dexamethasone Transiently Elevates Blood Glucose Levels and Reduces Pain After TKA in Patients With Type-2 Diabetes Mellitus: A Randomized Controlled Study,” Journal of Bone and Joint Surgery (American Volume) 107, no. 10 (2025): 1073–1081, https://doi.org/10.2106/jbjs.24.00984.
|
| [12] |
A. S. Punit, K. Sangani, B. N. Prashanth, I. Ismail, and S. S. Kumar, “Inflammatory Markers in Conventional vs. Active Robot-Assisted Total Knee Arthroplasty and Other Variables,” BMC Musculoskeletal Disorders 26, no. 1 (2025): 447, https://doi.org/10.1186/s12891-025-08585-0.
|
| [13] |
J. B. Meding, K. Reddleman, M. E. Keating, et al., “Total Knee Replacement in Patients With Diabetes Mellitus,” Clinical Orthopaedics and Related Research 416 (2003): 208–216, https://doi.org/10.1097/01.blo.0000093002.90435.56.
|
| [14] |
S. Li, H. Si, S. Zhang, J. Xu, Y. Liu, and B. Shen, “Does Diabetes Mellitus Impair the Clinical Results of Total Knee Arthroplasty Under Enhanced Recovery After Surgery?,” Journal of Orthopaedic Surgery and Research 18, no. 1 (2023): 490, https://doi.org/10.1186/s13018-023-03982-4.
|
| [15] |
M. L. Webb, N. S. Golinvaux, I. K. Ibe, P. Bovonratwet, M. S. Ellman, and J. N. Grauer, “Comparison of Perioperative Adverse Event Rates After Total Knee Arthroplasty in Patients With Diabetes: Insulin Dependence Makes a Difference,” Journal of Arthroplasty 32, no. 10 (2017): 2947–2951, https://doi.org/10.1016/j.arth.2017.04.032.
|
| [16] |
M. C. Baker, K. Sheth, Y. Liu, D. Lu, R. Lu, and W. H. Robinson, “Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea,” JAMA Network Open 6, no. 3 (2023): e233646, https://doi.org/10.1001/jamanetworkopen.2023.3646.
|
| [17] |
S. Chen, G. Ruan, M. Zeng, et al., “Association Between Metformin Use and Risk of Total Knee Arthroplasty and Degree of Knee Pain in Knee Osteoarthritis Patients With Diabetes and/or Obesity: A Retrospective Study,” Journal of Clinical Medicine 11, no. 16 (2022): 4796, https://doi.org/10.3390/jcm11164796.
|
| [18] |
B. Bai and H. Chen, “Metformin: A Novel Weapon Against Inflammation,” Frontiers in Pharmacology 12 (2021): 622262, https://doi.org/10.3389/fphar.2021.622262.
|
| [19] |
L. Qing, J. Fu, P. Wu, Z. Zhou, F. Yu, and J. Tang, “Metformin Induces the M2 Macrophage Polarization to Accelerate the Wound Healing via Regulating AMPK/mTOR/NLRP3 Inflammasome Singling Pathway,” American Journal of Translational Research 11, no. 2 (2019): 655–668.
|
| [20] |
M. Gharib, W. Elbaz, E. Darweesh, N. A. Sabri, and M. A. Shawki, “Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study,” Frontiers in Pharmacology 12 (2021): 726490, https://doi.org/10.3389/fphar.2021.726490.
|
| [21] |
F. Pan, Y. Wang, Y. Z. Lim, et al., “Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial,” Journal of the American Medical Association 333, no. 20 (2025): 1804–1812, https://doi.org/10.1001/jama.2025.3471.
|
| [22] |
Z. Zhu, J. Y. Huang, G. Ruan, et al., “Metformin Use and Associated Risk of Total Joint Replacement in Patients With Type 2 Diabetes: A Population-Based Matched Cohort Study,” CMAJ 194, no. 49 (2022): E1672–e1684, https://doi.org/10.1503/cmaj.220952.
|
| [23] |
J. M. Wilson, K. X. Farley, S. E. Broida, T. L. Bradbury, and G. N. Guild, “Metformin Use Is Associated With Fewer Complications in Patients With Type-2 Diabetes Undergoing Total Knee Arthroplasty: A Propensity Score-Matched Analysis,” Journal of Bone and Joint Surgery (American Volume) 103, no. 7 (2021): 601–608, https://doi.org/10.2106/jbjs.20.01535.
|
Rights & permissions
2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
(698KB)
